James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Alphabet Inc.: Is This the Sign That Google Inc. Has Peaked? (GOOGL)

What's in a name? It shouldn't matter if it's Alphabet Inc. or Google Inc. But funny things can happen when, where and how you least expect it.

Why JD.Com Inc. (JD), Groupon Inc. (GRPN) and Twenty-First Century Fox Inc. (FOX) Are 3 of Today’s Worst Stocks

JD.Com (JD), Groupon (GRPN) and Twenty-First Century Fox (FOX) would have rather just skipped Monday's trading. Here's what happened.

MannKind: Forget Earnings, MNKD Stock Is Still Speculative

It's certainly not for the faint of heart, but MNKD stock is worth a (small) shot based on the long-term potential of Afrezza.

What’s Berkshire Hathaway Getting for $37.2B? (BRK.B, PCP)

Berkshire Hathaway will soon be adding Precision Castparts to its portfolio, but why exactly is Buffett interested in PCP?

Why Sprouts Farmers Market Inc. (SFM), ACADIA Pharmaceuticals Inc. (ACAD) and Alnylam Pharmaceuticals, Inc. (ALNY) Are 3 of Today’s Worst Stocks

Sprouts Farmers Market (SFM), ACADIA Pharmaceuticals (ACAD) and Alnylam Pharmaceuticals (ALNY) were the worst of the worst on Friday.